These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 28770596)

  • 1. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Viral Suppression With Streamlined Care in the SEARCH Study.
    Hickey MD; Ayieko J; Kwarisiima D; Opel FJ; Owaraganise A; Balzer LB; Chamie G; Jain V; Peng J; Camlin C; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):571-578. PubMed ID: 32991337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.
    Petersen M; Balzer L; Kwarsiima D; Sang N; Chamie G; Ayieko J; Kabami J; Owaraganise A; Liegler T; Mwangwa F; Kadede K; Jain V; Plenty A; Brown L; Lavoy G; Schwab J; Black D; van der Laan M; Bukusi EA; Cohen CR; Clark TD; Charlebois E; Kamya M; Havlir D
    JAMA; 2017 Jun; 317(21):2196-2206. PubMed ID: 28586888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial.
    Jakubowski A; Snyman K; Kwarisiima D; Sang N; Burger R; Balzer L; Clark T; Chamie G; Shade S; Cohen C; Bukusi E; Charlebois E; Kamya M; Petersen M; Havlir D; Thirumurthy H
    PLoS One; 2018; 13(6):e0198912. PubMed ID: 29944678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
    Jain V; Petersen ML; Liegler T; Byonanebye DM; Kwarisiima D; Chamie G; Sang N; Black D; Clark TD; Ladai A; Plenty A; Kabami J; Ssemmondo E; Bukusi EA; Cohen CR; Charlebois ED; Kamya MR; Havlir DV;
    Lancet HIV; 2017 Mar; 4(3):e122-e133. PubMed ID: 27989576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
    BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.
    Kamya MR; Petersen ML; Kabami J; Ayieko J; Kwariisima D; Sang N; Clark TD; Schwab J; Charlebois ED; Cohen CR; Bukusi EA; Peng J; Jain V; Chen YH; Chamie G; Balzer LB; Havlir DV
    Clin Infect Dis; 2021 Oct; 73(7):e1938-e1945. PubMed ID: 33783495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys.
    Shade SB; Osmand T; Luo A; Aine R; Assurah E; Mwebaza B; Mwai D; Owaraganise A; Mwangwa F; Ayieko J; Black D; Brown LB; Clark TD; Kwarisiima D; Thirumurthy H; Cohen CR; Bukusi EA; Charlebois ED; Balzer L; Kamya MR; Petersen ML; Havlir DV; Jain V
    AIDS; 2018 Sep; 32(15):2179-2188. PubMed ID: 30134294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
    Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS
    PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
    Castelnuovo B; Kiragga A; Musaazi J; Sempa J; Mubiru F; Wanyama J; Wandera B; Kamya MR; Kambugu A
    PLoS One; 2015; 10(12):e0142722. PubMed ID: 26642214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa.
    Le Roux KW; Davis EC; Gaunt CB; Young C; Koussa M; Harris C; Rotheram-Borus MJ
    AIDS Patient Care STDS; 2019 Nov; 33(11):466-472. PubMed ID: 31682167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial.
    Gaur AH; Kizito H; Prasitsueubsai W; Rakhmanina N; Rassool M; Chakraborty R; Batra J; Kosalaraksa P; Luesomboon W; Porter D; Shao Y; Myers M; Ting L; SenGupta D; Quirk E; Rhee MS
    Lancet HIV; 2016 Dec; 3(12):e561-e568. PubMed ID: 27765666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
    Bahemana E; Esber A; Dear N; Ganesan K; Parikh A; Reed D; Maganga L; Khamadi S; Mizinduko M; Lwilla A; Mkondoo D; Mwaisanga G; Somi N; Owouth J; Maswai J; Kiweewa F; Iroezindu M; Ake JA; Crowell TA; Valcour VG; Polyak CS;
    AIDS Res Ther; 2020 Nov; 17(1):66. PubMed ID: 33183355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
    Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
    Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.